Commentary & Opinion
Opinion: Partnerships Under Medicines Patent Pool Key to Lowering Antiretroviral Therapy Costs
July 24, 2013
The ONE blog features an interview with Esteban Burrone, head of policy for the Medicines Patent Pool, who discusses how antiretroviral drugs used to treat HIV became less expensive over the past decade, allowing for millions more people living with the virus to receive treatment. Burrone says partnerships with pharmaceutical companies have been key in reducing the cost of treatment, and he adds, "Our focus is now on drugs under development and second- and third-line medicines, which patients need when they develop resistance" (7/23).
This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily Global Health Policy Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)